NCT03888378View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

September 18, 2020

Study Completion Date

February 1, 2021

Conditions
Meibomian Gland DysfunctionMGD-Meibomian Gland Dysfunction
Interventions
DRUG

0.3% Topical Minocycline Ointment

0.3% Topical Minocycline ointment to treat inflamed Meibomian Gland Dysfunction

DRUG

1% Topical Minocycline Ointment

1% Topical Minocycline ointment to treat inflamed Meibomian Gland Dysfunction

OTHER

Topical Vehicle Ointment

Topical vehicle ointment to treat inflamed Meibomian Gland Dysfunction

Trial Locations (20)

23502

Clinical site - 17, Norfolk

28803

Clinical site - 5, Asheville

32256

Clinical site - 15, Jacksonville

33773

Clinical Site - 18, Largo

38119

Clinical site - 2, Memphis

45040

Clinical site - 11, Mason

46260

Clinical site - 6, Indianapolis

47150

Clinical site - 20, New Albany

63131

Clinical site - 3, St Louis

Clinical site - 9, St Louis

64111

Clinical site - 19, Kansas City

77573

Clinical site - 8, League City

78613

Clinical site - 14, Cedar Park

79902

Clinical Site - 1, El Paso

89145

Clinical site - 7, Las Vegas

90301

Clinical site - 12, Inglewood

91345

Clinical site - 13, Mission Hills

91702

Clinical site - 4, Azusa

92647

Clinical site - 16, Huntington Beach

95670

Clinical site 10, Rancho Cordova

All Listed Sponsors
lead

Hovione Scientia Limited

INDUSTRY

NCT03888378 - Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter